Cite
HARVARD Citation
Yu, I. et al. (2022). Exceptional response to combination ipilimumab and nivolumab in metastatic uveal melanoma: Insights from genomic analysis. Melanoma research. 32 (4), pp. 278-285. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yu, I. et al. (2022). Exceptional response to combination ipilimumab and nivolumab in metastatic uveal melanoma: Insights from genomic analysis. Melanoma research. 32 (4), pp. 278-285. [Online].